Pim-2 activates api-5 to inhibit the apoptosis of hepatocellular carcinoma cells through nf-κb pathway

Pathology and Oncology Research

Volumn 16, Issue 2, 2010, Pages 229-237

  Ren, Ke ^a   Zhang, Wei ^a   Shi, Yujun ^b   Gong, Jianping ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

API 5; Apoptosis; Hepatocellular carcinoma cells; NF B; Pim 2

Indexed keywords

APOPTOSIS INHIBITOR 5; CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; ONCOPROTEIN; PARTHENOLIDE; PROTEIN PIM 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 77955714741     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9215-4     Document Type: Article

References (26)

1. Breuer ML, Cuypers HT, Berns A (1989) Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J 8(3):743-7488
2. Ren K, Shi YJ, Gong JP (2007) The research on the mechanism of Pim-2 suppressing the apoptosis of tumor cell. Prog Physiol Sci 38 (2):136-139
3. Chen JL, Limnander A, Rothman PB (2008) Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene. Blood 111(3):1677-1685
4. Dai H, Li R, Wheeler T et al. (2005) Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate 65(3):276-286
5. Gong J, Wang J, Ren K et al. (2008) Serine/Threonine Kinase Pim-2 Promotes Liver Tumorigenesis Induction through Mediating Survival and Preventing Apoptosis of Liver Cell. J Surg Res. Apr 22. [Epub ahead of print]
6. Li B, Ye T, Li DH (2008) Expression of Pim-2 in normal liver and hepatocellular carcinoma tissues. Chinese J Hepatol 16(12):950-951
7. Hammerman PS, Fox CJ, Cinalli RM et al. (2004) Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation. Cancer Res 64:8341-8348
8. Aghajanian C, Soignet S, Dizon DS et al. (2002) A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clin Cancer Res 8:2505-2511
9. White E (2003) The pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev 17:1813-1816
10. Macdonald A, Campbell DG, Toth R et al. (2006) Pim kinases phosphorylate multiple sites on Bad and promote14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 7:1186-1471
11. Peng C, Knebel A, Morrice NA et al. (2007) Pim kinase substrate identification and specificity. J Biochem 141(3):353-62
12. Wang Y, Lee AT, Ma JZ et al. (2008) Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224 specific target. J Biol Chem 283(19):13205-15
13. Hehner SP, Hofmann TG, Dröge W et al. (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163 (10):5617-23
14. Li W, Lei P, Yu B et al. (2008) Screening and identification of a novel target specific for hepatoma cell line HepG2 from the FliTrx bacterial peptide library. Acta Biochim Biophys Sin 40 (5):443-51
15. Guzman ML, Rossi RM, Karnischky L et al. (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105(11):4163-9
16. Jiang JX, Mikami K, Venugopal S et al. (2009) Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 51(1):139-48
17. Hoffmann F, Sass G, Zillies J et al. (2009) A novel technique for selective NF-kappaB inhibition in Kupffer cells - contrary effects in fulminant hepatitis and ischemia/reperfusion. Gut May 25. [Epub ahead of print]
18. Kuboki S, Sakai N, Clarke C et al. (2009) The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury. J Hepatol May 24. [Epub ahead of print]
19. Pelengaris S, Khan M, Evan G (2002) c-Myc: more than just a matter of life and death. Nature Reviews. Cancer 2(10):764-776
20. Hammerman PS, Fox CJ, Cinalli RM et al. (2004) Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation. Cancer Res 64:8341-8348
21. Zhang Y, Wang Z, Li X et al. (2008) Pim kinase-dependent inhibition of c-Myc degradation. Oncogene 27(35):4809-19
22. Bachmann M, Moroy T (2005) The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37:726-730
23. Fujii C, Nakamoto Y, Lu P et al. (2005) Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer 114(2):209-218
24. Qian K, Wang L, Cywin CL et al. (2009) Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode. J Med Chem 52(7):1814-27
25. Xia Z, Knaak C, Ma J et al. (2009) Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases. J Med Chem 52(1):74-86
26. Tong Y, Stewart KD, Thomas S et al. (2008) Isoxazolo [3, 4-b] quinoline-3, 4 (1H, 9H) -diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling. Bioorg Med Chem Lett 18 (19):5206-5208